Vanguard Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $38.4M | Sell |
|
|||||
|
2023
Q2 | $51.9M | Buy |
|
|||||
|
2023
Q1 | $52.9M | Buy |
|
|||||
|
2022
Q4 | $45M | Buy |
|
|||||
|
2022
Q3 | $37.8M | Buy |
|
|||||
|
2022
Q2 | $34.7M | Buy |
|
|||||
|
2022
Q1 | $38.9M | Buy |
|
|||||
|
2021
Q4 | $32.1M | Sell |
|
|||||
|
2021
Q3 | $42M | Sell |
|
|||||
|
2021
Q2 | $67.4M | Buy |
|
|||||
|
2021
Q1 | $76.1M | Buy |
|
|||||
|
2020
Q4 | $69.9M | Buy |
|
|||||
|
2020
Q3 | $114M | Buy |
|
|||||
|
2020
Q2 | $119M | Buy |
|
|||||
|
2020
Q1 | $148M | Buy |
|
|||||
|
2019
Q4 | $285M | Sell |
|
|||||
|
2019
Q3 | $153M | Sell |
|
|||||
|
2019
Q2 | $186M | Buy |
|
|||||
|
2019
Q1 | $228M | Buy |
|
|||||
|
2018
Q4 | $202M | Buy |
|
|||||
|
2018
Q3 | $247M | Buy |
|
|||||
|
2018
Q2 | $159M | Buy |
|
|||||
|
2018
Q1 | $89M | Buy |
|
|||||
|
2017
Q4 | $82.1M | Buy |
|
|||||
|
2017
Q3 | $80.3M | Buy |
|
|||||
|
2017
Q2 | $161M | Buy |
|
|||||
|
2017
Q1 | $144M | Buy |
|
|||||
|
2016
Q4 | $132M | Buy |
|
|||||
|
2016
Q3 | $194M | Buy |
|
|||||
|
2016
Q2 | $164M | Buy |
|
|||||
|
2016
Q1 | $142M | Buy |
|
|||||
|
2015
Q4 | $163M | Buy |
|
|||||
|
2015
Q3 | $174M | Buy |
|
|||||
|
2015
Q2 | $242M | Buy |
|
|||||
|
2015
Q1 | $269M | Buy |
|
|||||
|
2014
Q4 | $118M | Buy |
|
|||||
|
2014
Q3 | $172M | Buy |
|
|||||
|
2014
Q2 | $154M | Buy |
|
|||||
|
2014
Q1 | $192M | Buy |
|
|||||
|
2013
Q4 | $18.1M | Buy |
|
|||||
|
2013
Q3 | $13.2M | Buy |
|
|||||
|
2013
Q2 | $8.29M | Buy |
|